Sign In
Buy BIO
$304.83
-1.30 (-0.425%)
At Close: Jun 03, 2026
Bruker (BRKR) to Support Biopharma Industries With New Buyout
01:25pm, Wednesday, 06'th Apr 2022 Zacks Investment Research
Bruker's (BRKR) recent buyout strengthens the company as a key software and solutions provider for small molecule, biologics and new drug modalities pharma companies.
Medtronic (MDT) Innovations Aid Global Growth, Volume Woe Stays
01:09pm, Tuesday, 05'th Apr 2022 Zacks Investment Research
In the neuroscience portfolio, Medtronic (/MDT) is gaining market share in Cranial and Spinal technologies.
Abbott (ABT) Aveir VR Leadless Pacemaker Receives FDA Nod
12:57pm, Tuesday, 05'th Apr 2022 Zacks Investment Research
Abbott's (ABT) Aveir VR is a leadless pacemaker designed to treat patients with slow heart rhythms in the United States.
STERIS (STE) Hits a New 52-Week High: What's Driving It?
01:52pm, Monday, 04'th Apr 2022 Zacks Investment Research
Investors are optimistic about STERIS (STE) on impressive growth across its operating segments.
Here's Why You Should Retain CVS Health (CVS) Stock For Now
01:51pm, Monday, 04'th Apr 2022 Zacks Investment Research
Investors are optimistic about CVS Health (CVS) owing to continued progress in its consumer-centric digital solutions.
Bio-Rad (BIO) Thrives on Global Sales and Testing Uptake
01:15pm, Friday, 01'st Apr 2022 Zacks Investment Research
Bio-Rad's (BIO) underlying Life Science business' core revenues grow on strong uptake of Droplet Digital PCR as well as the qPCR business.
Bio-Rad (BIO) Thrives on Global Sales and Testing Uptake
10:32am, Friday, 01'st Apr 2022
Bio-Rad's (BIO) underlying Life Science business' core revenues grow on strong uptake of Droplet Digital PCR as well as the qPCR business.
Here's Why You Should Hold on to Exact Sciences (EXAS) Stock
12:54pm, Thursday, 31'st Mar 2022 Zacks Investment Research
Investors are optimistic about Exact Sciences (EXAS) on strong buoyed by Cologuard volume growth.
Omnicell (OMCL) Progresses With Intelligent Infrastructure Tools
03:22pm, Wednesday, 30'th Mar 2022 Zacks Investment Research
Omnicell's (OMCL) IVX Station robotic compounding technology apparently supports three times the throughput speed of the current IV robotic technology.
Edwards Lifesciences (EW) Up 7.5% Since Q4 Earnings Release
12:43pm, Wednesday, 30'th Mar 2022 Zacks Investment Research
Edwards Lifesciences' (EW) stock rallies on impressive fourth-quarter performance and bullish 2022 guidance.
Bio-Rad Laboratories: Cutting Edge Tech And Financial Success
06:26am, Wednesday, 30'th Mar 2022
Bio-Rad Laboratories provides a range of products for the life science and clinical diagnostics markets.
Here's Why You Should Hold on to Align Technology (ALGN) Now
12:59pm, Tuesday, 29'th Mar 2022 Zacks Investment Research
Investors are optimistic about Align Technology (ALGN) on the growing market adoption of the iTero Element 5D Plus imaging system.
Alcon (ALC) Publishes Dividend, New Board Member Addition Plans
04:21pm, Monday, 28'th Mar 2022 Zacks Investment Research
Alcon's 2022 AGM is set to take place in a closed format without the personal presence of shareholders.
Neogen's (NEOG) Q3 Earnings Miss Estimates, Margins Down
04:54pm, Friday, 25'th Mar 2022 Zacks Investment Research
Robust segmental performance and contributions from the Soleris product line drive the top line for Neogen (NEOG) in third-quarter of fiscal 2022 results.
Here's Why You Should Hold on to Thermo Fisher (TMO) Stock Now
04:08pm, Thursday, 24'th Mar 2022 Zacks Investment Research
Investors are optimistic about Thermo Fisher (TMO) on its progress with COVID-19-related products and services.
